BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Acura Pharmaceuticals, Inc. 

616 N. North Court
Suite 120
Palatine  Illinois  60067  U.S.A.
Phone: 847-705-7709 Fax: 847-705-5399


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Acura Pharmaceuticals, Inc. (ACUR) Walks Away From Pfizer Inc. (PFE) Licensing Pact 4/11/2014 7:12:05 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) To Present At The 26th Annual ROTH Conference 3/6/2014 9:53:35 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) Announces Fourth Quarter And Full Year 2013 Financial Results 3/5/2014 11:09:49 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) To Host 2013 Financial Results Conference Call On March 4, 2014 2/19/2014 10:27:25 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) Wraps Up $10.0 Million Debt Financing Round 12/31/2013 9:04:34 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) Provides Update On Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug Development 12/9/2013 11:21:08 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) Announces Settlement of Oxecta® Patent Litigation With Par Pharmaceutical, Inc. and IMPAX Laboratories, Inc. (IPXL) 10/10/2013 8:48:54 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) Provides Update on NEXAFED® Launch 9/19/2013 10:44:41 AM    More...
Acura Pharmaceuticals, Inc. (ACUR)'s Abuse-Deterrent Pain Drug Fails Phase 2 Study Goal; Stock Falls -19.79% at Market Close (August 27, 2013) 8/27/2013 6:55:06 AM    More...
Acura Pharmaceuticals, Inc. (ACUR) to Host Second Quarter 2013 Financial Results Conference Call on August 2, 2013 7/29/2013 9:51:05 AM    More...
12345678910...

//-->